Newsroom

Categories: Drug Discovery & Development, Clinical Research & Trials

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.

January 9, 2026

Categories: Biotechnology, Drug Discovery & Development

Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug screening and toxicology

October 9, 2025

Categories: Drug Discovery & Development, Pharma

Takara Bio Europe launches Cellartis® MSC EV Wonder™, a defined, xeno-free medium for high-yield EV production

September 24, 2025

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

September 3, 2025

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Diagnostics

Aptamer Group introduces novel biomarker discovery service

August 28, 2025

Categories: Omics & Genetics, Drug Discovery & Development, Corporate, Finance & Investor

GenNext Technologies and Thermo Fisher Scientific collaborate to simplify structural biology for faster biotherapeutic development

May 7, 2025

Categories: Biotechnology, Drug Discovery & Development

EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery

April 24, 2025

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Indivumed celebrates milestone of its patient-centric R&D platform: Numerous novel cancer targets discovered for first-in-class therapeutics

April 8, 2025

Categories: Healthcare, Computing & Technology, Drug Discovery & Development, Corporate, Finance & Investor, Clinical Diagnostics

Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform

January 8, 2025